Building a 21st Century Workforce to Develop Tomorrow's New Medicines
Continued scientific and technological innovations are critical to fostering sustained economic growth, global competitiveness, and most importantly, helping patients live longer, healthier, and more productive lives. The U.S. innovative biopharmaceutical industry is committed to building on new scientific discoveries and technological advances, relying on a workforce with education and skills in science, technology, engineering, and math (STEM). Around the world, an increasing number of countries have recognized that a robust STEM skilled workforce is needed to fuel continued economic growth. STEM workers have been shown to be key drivers of innovation and, thus, contribute significantly to economic productivity.